2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task …

GN Levine, ER Bates, JC Blankenship… - Journal of the American …, 2011 - jacc.org
Interventions. Copies: This document is available on the World Wide Web sites of the
American College of Cardiology (www. cardiosource. org), the American Heart Association …

Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis

J Silvain, F Beygui, O Barthélémy, C Pollack, M Cohen… - Bmj, 2012 - bmj.com
Objective To determine the efficacy and safety of enoxaparin compared with unfractionated
heparin during percutaneous coronary intervention. Design Systematic review and meta …

2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: executive summary: a report of the American College of …

EA Amsterdam, NK Wenger, RG Brindis, DE Casey Jr… - Circulation, 2014 - Am Heart Assoc
The recommendations listed in this CPG are, whenever possible, evidence based. An
extensive evidence review was conducted through October 2012, and other selected …

Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous …

Y Li, Z Liang, L Qin, M Wang, X Wang, H Zhang, Y Liu… - The Lancet, 2022 - thelancet.com
Background Previous randomised trials of bivalirudin versus heparin in patients with ST-
segment elevation myocardial infarction (STEMI) undergoing primary percutaneous …

2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American …

EA Amsterdam, NK Wenger, RG Brindis… - Journal of the American …, 2014 - jacc.org
The recommendations listed in this CPG are, whenever possible, evidence based. An
extensive evidence review was conducted through October 2012, and other selected …

2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary: a report of the American College of Cardiology Foundation/American …

Writing Committee Members*, GN Levine, ER Bates… - Circulation, 2011 - Am Heart Assoc
The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted through November 2010, as well as selected …

2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary: a report of the American College of Cardiology Foundation/American …

GN Levine, ER Bates, JC Blankenship… - Catheterization and …, 2012 - Wiley Online Library
Steven M. Ettinger, MD, FACC, Robert A. Guyton, MD, FACC, Jonathan L. Halperin, MD,
FACC, FAHA, Judith S. Hochman, MD, FACC, FAHA, Frederick G. Kushner, MD, FACC …

Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study

M Pieri, N Agracheva, E Bonaveglio, T Greco… - Journal of cardiothoracic …, 2013 - Elsevier
OBJECTIVE: Heparin-based anticoagulation for patients undergoing extracorporeal
membrane oxygenation has many limitations, including a high risk of heparin-induced …

Neutrophil to lymphocyte ratio and the extent of coronary artery disease: results from a large cohort study

M Verdoia, L Barbieri, G Di Giovine, P Marino… - …, 2016 - journals.sagepub.com
The neutrophil to lymphocyte ratio (NLR), an inflammatory biomarker, may be of predictive
and prognostic value for cardiovascular (CV) events. We evaluated the relationship of NLR …

Thrombin as a multi-functional enzyme

JM Siller-Matula, M Schwameis, A Blann… - Thrombosis and …, 2011 - thieme-connect.com
Thrombin is the central protease in the coagulation cascade and one of the most extensively
studied of all enzymes. In addition to its recognised role in the coagulation cascade and …